Vor Biopharma Inc.
Company Stats
- Market Cap
- $1.1B
- as of Sep 30, 2026
- Shares Outstanding
- 59.2M
- Free Float
- 30.9%
Income Statement
- Operating Income
- -$371.6M
- Net Income
- -$696.0M
- EBITDA
- -$368.8M
Cash Flow
- Free Cash Flow
- -$143.7M
- FCF Yield
- -12.7%
- Owner FCF Yield
- -14.4%
Balance Sheet
- Cash & Equivalents
- $396.5M
Returns & Capital
- SBC, 3Y Avg
- $14.0M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$143.7M | — |
| FY2024 | — | -$99.9M | — |
| FY2023 | — | -$101.4M | — |
| FY2022 | — | -$93.6M | — |
| FY2021 | — | -$73.0M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of November 5, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.